skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi .... Further to your answer to Guy's question and as someone who is hurting big time with rht .... does your answer mean that there are no catalysts anticipated in the next year to lift this stock - other than an unanticipated piece of good news? No excellent fundamentals?

As 'they" say, hope is not a strategy.... so my impression is that if you were putting new money to work RHT would be way down your list of candidates?

Thanks for your help here. I hate to walk away from an investment but this looks like it is overdue to be dumped.
Read Answer Asked by Donald on September 26, 2018
Q: whats your overall thoughts on retail in Canada in general? all these retail names have expeirenced sizable pull backs, and are looking more attractive now. is the strength of the consumer that large of a threat?
Read Answer Asked by matthew on September 25, 2018
Q: Re my question on H-IR, the receipts are trading around $27 and H is trading around $19 - 20. If the deal goes through what do I get for one H-IR? The press release which I read, and which you quoted did not make this clear to me. I assume I would not be trading a $27 H-IR for a share of H worth $20. (or would I ?)
And, also, what specifically would I receive if the deal does not go through?
Thanks,
Read Answer Asked by Peter on September 25, 2018
Q: It is difficult to evaluate the cannabis industry at this early stage. I wonder if I can get your opinion on the Medical side of the industry. With a longer term outlook and possibly our Canadian companies supplying the world with high grade medical cannabis, can you talk a little about the Companies you like in order of perference?
Read Answer Asked by Randy on September 25, 2018
Q: COR, the US data center REIT, is down 7% in the first 2 hours today . There was one downgrade---just one analyst (Cowen). I have searched for other news and found none. I don't have the Cowen report; perhaps you have access? Other analysts have not reported anything negative. And neither is there any other news [ yet] that I could find to justify the suden report. Granted, based on just numbers alone COR did look overvalued, and Robos did conclude that as they are based on just robotic (automated) analytics. So, what has changed? It is tempting to buy COR.(the Ex-div is a couple of days yet holders are dumping). Clearly , the market knows something that has not yet been reported. What gives, do you know/can you tell? Does Cowen have THIS much impact? I doubt that, so there must be something else surely? What is your view on today’s price on this US REIT? You have favored COR.us in the recent past.
Read Answer Asked by Adam on September 25, 2018
Q: Regarding my earlier q on NRGY you mentioned that it was trading at a discount of around 3.5% and explained that there were some good reasons not to like the mutual fund that it would roll into.
But given that closed it closed at 5.52 and Ninepoint shows NAV as 6.03 it could - at that price - be purchased at a discount of about 8%, no? If that were the case, would it not have made sense - apart from the commodity risk - for a fund which will close in about 4 weeks and for which an investor would receive its NAV?
(I was really asking whether I was missing something in the conversion process from NRGY to NPP008)
Read Answer Asked by Peter on September 25, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!